Your browser is no longer supported. Please, upgrade your browser.
Settings
NTEC Intec Pharma Ltd. daily Stock Chart
NTEC [NASD]
Intec Pharma Ltd.
Index- P/E- EPS (ttm)-1.28 Insider Own16.08% Shs Outstand33.30M Perf Week-12.16%
Market Cap23.98M Forward P/E- EPS next Y-0.47 Insider Trans4.80% Shs Float25.95M Perf Month-37.38%
Income- PEG- EPS next Q-0.20 Inst Own40.23% Short Float4.13% Perf Quarter-78.70%
Sales- P/S- EPS this Y31.40% Inst Trans- Short Ratio0.42 Perf Half Y-88.66%
Book/sh1.05 P/B0.68 EPS next Y51.00% ROA- Target Price8.83 Perf Year-84.41%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.41 - 9.25 Perf YTD-90.45%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-92.11% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low78.07% ATR0.13
Employees70 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)47.38 Volatility8.58% 16.00%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.16 Prev Close0.72
ShortableYes LT Debt/Eq- EarningsNov 08 AMC Payout- Avg Volume2.53M Price0.73
Recom2.80 SMA20-13.05% SMA502.67% SMA200-84.45% Volume71,106 Change1.39%
Oct-11-19Downgrade ROTH Capital Buy → Neutral $10 → $1
Mar-26-18Reiterated Maxim Group Buy $8 → $12
Feb-28-18Initiated Ladenburg Thalmann Buy
Feb-26-18Initiated H.C. Wainwright Buy
Sep-21-17Reiterated Oppenheimer Outperform $10 → $15
Sep-16-15Initiated Maxim Group Buy $9
Sep-11-15Initiated ROTH Capital Buy $9.50
Sep-30-19 07:20PM  Top Marijuana Stocks on the NASDAQ Investopedia
Sep-25-19 07:00AM  Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society PR Newswire -6.30%
Sep-16-19 07:00AM  Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society PR Newswire +8.70%
Sep-03-19 07:00AM  Intec Pharma to Participate in September Investment Conferences PR Newswire
Aug-30-19 11:28AM  7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk InvestorPlace
08:52AM  Implied Volatility Surging for Intec Pharma (NTEC) Stock Options Zacks
Aug-13-19 10:09AM  Can European Expansion Aid Canopy Growth (CGC) Q1 Earnings? Zacks +30.18%
Aug-09-19 07:00AM  Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update PR Newswire
Aug-06-19 12:00PM  ArQule (ARQL) to Post Q2 Earnings: What's in the Cards? Zacks
Jul-22-19 10:15AM  Intec Shares Slammed As Advanced Parkinson's Disease Drug Combo Flunks Late-Stage Study Benzinga -81.61%
08:56AM  Intec stock plunges 80% after late-stage failure of Parkinson's drug MarketWatch
07:00AM  Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients PR Newswire
Jul-03-19 05:00PM  Horizons ETFs Rebalances Marijuana-Focused ETFs CNW Group
Jul-01-19 09:00AM  Intec Pharma Announces Publication of Article Reviewing Accordion Pill's Unique Gastric Retention Platform in Therapeutic Delivery PR Newswire -5.07%
Jun-28-19 05:45PM  Heres What Hedge Funds Think About Intec Pharma Ltd (NTEC) Insider Monkey
Jun-25-19 07:00AM  Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related Disorders PR Newswire
Jun-19-19 07:00AM  Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders PR Newswire -12.55%
May-28-19 07:00AM  Intec Pharma to Participate at June Investment Conferences PR Newswire
May-20-19 07:00AM  Intec Pharma Granted European Patent PR Newswire
May-16-19 06:00AM  Intec Pharma Announces Research Collaboration Agreement With Merck PR Newswire
May-07-19 07:00AM  Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update PR Newswire
May-02-19 07:00AM  Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders PR Newswire
Apr-30-19 07:00AM  Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients PR Newswire
Apr-24-19 11:30AM  The New Cannabis ETF Is Already Making Additions Benzinga
Apr-01-19 07:00AM  Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference PR Newswire
Mar-27-19 06:00AM  A Trio of Indirect Cannabis Plays MoneyShow
Mar-13-19 07:00AM  Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference PR Newswire +5.40%
Feb-28-19 09:42AM  Intec Pharma to Participate at Four Investment Conferences in March PR Newswire
Feb-27-19 07:00AM  Intec Pharma Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Update PR Newswire
Feb-20-19 10:03AM  Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More Zacks
Feb-19-19 07:00AM  Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily PR Newswire
Jan-04-19 07:00AM  Cannabis Stock News Daily Roundup January 4 Market Exclusive
Jan-02-19 07:00AM  Intec Pharma Advances Medical Cannabinoid Development Program With Dosing of First Patient in a Phase 1 Pharmacokinetic Study of Accordion Pill-THC PR Newswire +5.70%
Dec-23-18 02:39AM  Should You Buy Intec Pharma Ltd (NTEC)? Insider Monkey
Dec-19-18 09:28AM  Intec Pharma Publishes Letter to Shareholders PR Newswire -5.36%
Dec-13-18 09:15AM  Morning Rally Bends but Doesn't Break Zacks
Dec-11-18 10:37AM  Is Intec Pharma a Sleeping Blockbuster Play? GuruFocus.com
Dec-06-18 07:00AM  Intec Pharma to Continue Development Collaboration to Next Phase PR Newswire
Dec-03-18 06:50AM  Today's Research Reports on Trending Tickers: Oragenics and Intec Pharma ACCESSWIRE +10.55%
Nov-21-18 08:55AM  Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-09-18 07:00AM  Intec Pharma Reports Third Quarter 2018 Financial Results and Corporate Update PR Newswire
Nov-07-18 09:43AM  Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019 Reuters
Nov-06-18 07:00AM  Intec Pharma to Participate in Upcoming November Investment Conferences PR Newswire
Nov-02-18 12:15PM  A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies Benzinga
Oct-22-18 07:00AM  Intec Pharma Completes Enrollment of Pivotal Phase 3 Clinical Trial of Accordion Pill Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients PR Newswire
Sep-25-18 07:00AM  Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society PR Newswire +11.11%
Sep-20-18 07:00AM  Intec Pharma to Participate at Upcoming Investment Conferences PR Newswire
Aug-15-18 07:30AM  Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update PR Newswire
Jul-20-18 06:00AM  5 Favorite Biotech Bets Investopedia
Jun-29-18 07:00AM  Intec Pharma Appoints William Bradley Hayes to Board of Directors PR Newswire
May-31-18 08:30AM  Intec Pharma to Present at Jefferies 2018 Healthcare Conference PR Newswire
May-15-18 07:00AM  Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update PR Newswire
Apr-26-18 07:40AM  Blog Exposure - Intec Pharma Shares Phase-1 PK and Safety Data from Accordion Pill Carbidopa/Levodopa at AAN Annual Meeting ACCESSWIRE
Apr-24-18 07:00AM  Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting PR Newswire
Apr-13-18 04:01PM  Intec Pharma Announces Closing of $35.4 Million Public Offering of Ordinary Shares PR Newswire
Apr-11-18 09:00AM  Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares PR Newswire -17.97%
Apr-10-18 04:01PM  Intec Pharma Announces Proposed Public Offering of Ordinary Shares PR Newswire
10:00AM  Intec Pharma (Nasdaq: NTEC) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Apr-04-18 08:00AM  Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting PR Newswire
Apr-03-18 08:00AM  Intec Pharma Ltd. to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease PR Newswire
Mar-26-18 07:00AM  Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors PR Newswire
Mar-12-18 04:30PM  Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson's Disease PR Newswire
Mar-09-18 07:00AM  Intec Pharma Reports Fourth Quarter and Year End 2017 Financial Results and Business Update PR Newswire +6.45%
Mar-05-18 07:15AM  Intec Pharma, Ltd. to Present at Four Investor Conferences in March PR Newswire
Jan-31-18 08:00AM  Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer PR Newswire
Jan-08-18 08:00AM  Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company PR Newswire
Jan-06-18 03:23PM  Pot Stock Winners of the Week Investopedia
Jan-03-18 08:00AM  Intec Pharma Granted Patent in Canada for Accordion Pill Carbidopa / Levodopa PR Newswire +7.44%
Nov-15-17 04:01PM  Intec Pharma Reports Third Quarter 2017 Operating and Financial Results PR Newswire
Nov-08-17 08:00AM  Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference PR Newswire
Nov-01-17 07:00AM  Intec Pharma, Ltd. Announces Changes to its Board of Directors PR Newswire
07:00AM  Intec Pharma Ltd. Announces Changes to its Board of Directors PR Newswire
Oct-26-17 07:00AM  Intec Pharma Names Walt Linscott as Chief Administrative Officer PR Newswire
Oct-06-17 07:00AM  Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit PR Newswire
Sep-29-17 05:18PM  Pot Stock Winners of the Week Investopedia
Sep-20-17 07:00AM  Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference PR Newswire
Sep-08-17 10:38AM  Intec Pharma to Participate in the 19th Annual Rodman & Renshaw Global Investment Conference PR Newswire
Sep-01-17 08:00AM  Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry Conference PR Newswire
Aug-22-17 08:15AM  Intec Pharma (NTEC) Catches Eye: Stock Adds 9.8% in Session Zacks
Aug-21-17 04:15PM  Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares PR Newswire
Aug-16-17 09:00AM  Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares PR Newswire
Aug-15-17 04:01PM  Intec Pharma Announces Proposed Public Offering of Ordinary Shares PR Newswire
Aug-09-17 05:00PM  Intec Pharma Reports Financial Results for the First Six Months of 2017 PR Newswire
Aug-03-17 07:00AM  Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies PR Newswire
Jul-27-17 08:00AM  Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer PR Newswire
Jul-19-17 08:00AM  Intec Pharma Granted Patent in Hong Kong for Accordion Pill Carbidopa / Levodopa PR Newswire
Jul-10-17 08:33AM  Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer PR Newswire
May-31-17 08:49AM  Intec Pharma to Participate at Upcoming June Conferences Business Wire
May-24-17 08:30AM  Intec Pharma Granted U.S. Patent for Accordion Pill Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms PR Newswire
May-03-17 04:00AM  Intec Pharma Announces CEO Change PR Newswire
Apr-09-17 02:15AM  Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman PR Newswire
Apr-07-17 08:00AM  Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results PR Newswire
Mar-29-17 07:30AM  Intec Pharma Provides Update on Phase III ACCORDANCE Study of the Accordion Pill Carbidopa/Levodopa in Parkinson's Disease Patients PR Newswire
Mar-22-17 07:00AM  Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies PR Newswire
Mar-17-17 04:00PM  Intec Pharma to Participate in the Oppenheimer 27th Annual Healthcare Conference PR Newswire
Mar-10-17 08:54AM  Intec Pharma to Participate in the 29th Annual Roth Conference Business Wire
08:00AM  Intec Pharma Announces $10 Million Private Placement PR Newswire
Nov-28-16 07:30AM  Intec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment PR Newswire
Nov-09-16 07:30AM  Intec Pharma to Sponsor Investigator Meeting for Pivotal Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients PR Newswire
Nov-07-16 06:00AM  Intec Pharma Announces Protocol Amendment to Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients PR Newswire
Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various indications, including low back pain, neuropathic pain, and fibromyalgia. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd. in March 2004. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meckler Jeffrey AChief Executive OfficerAug 28Buy0.6820,00013,620196,761Aug 29 04:16 PM
MADDALUNA ANTHONY JDirectorAug 27Buy0.4725,00011,75053,570Aug 29 04:16 PM
KOZARICH JOHN WDirectorAug 23Buy0.46100,00045,900151,761Aug 27 04:20 PM
Meckler Jeffrey AChief Executive OfficerAug 23Buy0.46100,00045,700176,761Aug 27 04:18 PM